7-     Murray M, Lumpkin MD. FDA Public Health Advisory: Reports of diabetes and hyperglycemia in patients receiving Protease Inhibitors for the treatment of Human Inmunodeficiency Virus (HIV). Bethesda, MD: Food and drug administration 1997 .

8-     Fehmida V, Kruese K, Musher D. Severe Diabetis associated with Protease Inhibitor Therapy.   Annals of Intern Med 1997; 127:947

9-     Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral  therapy related lipodistrophy.

10-  Gopinath et al. Chronic lactic acidosis in a patient with acquired  immunodeficiency syndrome and lactic mitochondrial miopathy: biochemical studies. J Am Soc Nephrol1992;3:1212-9.

11-  Chattha G, Arieff A, Cummings C, Tierney L. Lactic acidosis complicating the Acquired Immunodeficiency Syndrome.   Annals Intern Med1993; 118:37-9

12- Odeh M. The role of the necrosis tumoral factor alfa in acquired  immunodeficiency   syndrome.
Autor: FUNDACION SANTAFE DE BOGOTA
 
<< Pgina Anterior           Pgina Siguiente >> 

[Pgina 1]    [Pgina 2]    [Pgina 3]    [Pgina 4]    [Pgina 5]    [Pgina 6]    
[Pgina 7]    [Pgina 8]    [Pgina 9]    [Pgina 10]    [Pgina 11]    [Pgina 12]    
[Pgina 13]    [Pgina 14]